PLANNING AND EVALUATION ABSTRACT The objectives of the Cancer Center Planning and Evaluation Core is to define the mission and vision of the Cancer Center, to define the strategies to accomplish this mission, to formulate plans for implementation of these strategies, and to track and evaluate the progress of the Center in achieving its mission and the objectives of the NCI and UAB. Planning and evaluation are accomplished through several well-established mechanisms using, for the most part, a Committee structure. Collectively, these mechanisms involve all senior leaders, program leaders, shared resource directors, and periodically the entire center membership, as well as external input. 1. Utilize planning and evaluation to strengthen and consolidate the existing Cancer Center; to further develop the cross-cutting themes (Translational Medicine, Energetics and Cancer, and Systems Biomedicine) and to integrate into the research programs; and to develop a Cancer Outcome and Survivorship initiative. 2. To integrate the goals and objectives of the CCC into the AMC21 Reload School of Medicine areas of research focus. a) Personalized Medicine/Genomics b) Informatics c) Outcomes/Health Disparities/Population Health d) Fundamentals of Basic Science Discovery e) Inflammation, Immunity and Infection 3. Consolidate collaborations between the CCC and the UAB/HudsonAlpha Center for Genomic Medicine and the UAB Institute for Informatics. 4. In late 2015 or early 2016, begin strategic planning for the CCC that refreshes the major CCC themes of Translational Therapeutics, Energetics and Cancer, and Systems Biology and integrate with the SOM research focus areas, all of which are highly relevant to our CCC themes, vision, and directions for the next funding cycle.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA013148-48
Application #
9895638
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
48
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Jimenez, Rachel V; Wright, Tyler T; Jones, Nicholas R et al. (2018) C-Reactive Protein Impairs Dendritic Cell Development, Maturation, and Function: Implications for Peripheral Tolerance. Front Immunol 9:372
Engle, Staci E; Antonellis, Patrick J; Whitehouse, Logan S et al. (2018) A CreER mouse to study melanin concentrating hormone signaling in the developing brain. Genesis 56:e23217
Van Arsdale, Anne R; Arend, Rebecca C; Cossio, Maria J et al. (2018) Insulin-like growth factor 2: a poor prognostic biomarker linked to racial disparity in women with uterine carcinosarcoma. Cancer Med 7:616-625
Kim, Harrison (2018) Modification of population based arterial input function to incorporate individual variation. Magn Reson Imaging 45:66-71
Leath 3rd, Charles A; Monk, Bradley J (2018) Twenty-first century cervical cancer management: A historical perspective of the gynecologic oncology group/NRG oncology over the past twenty years. Gynecol Oncol 150:391-397
Park, Misun; Yoon, Young Sup (2018) Cardiac Regeneration with Human Pluripotent Stem Cell-Derived Cardiomyocytes. Korean Circ J 48:974-988
Toboni, Michael D; Smith, Haller J; Bae, Sejong et al. (2018) Predictors of Unplanned Reoperation for Ovarian Cancer Patients From the National Surgical Quality Improvement Program Database. Int J Gynecol Cancer 28:1427-1431
Dionne-Odom, J Nicholas; Applebaum, Allison J; Ornstein, Katherine A et al. (2018) Participation and interest in support services among family caregivers of older adults with cancer. Psychooncology 27:969-976
Demark-Wahnefried, Wendy; Schmitz, Kathryn H; Alfano, Catherine M et al. (2018) Weight management and physical activity throughout the cancer care continuum. CA Cancer J Clin 68:64-89
Bandari, Shyam K; Purushothaman, Anurag; Ramani, Vishnu C et al. (2018) Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior. Matrix Biol 65:104-118

Showing the most recent 10 out of 747 publications